CrossBridge Bio operates as a biotechnology company.
CrossBridge Bio has raised $10.0M in total funding. The most recent round was Seed. The last funding was announced in November 2024.
CrossBridge Bio's investors include Alexandria Venture Investments, Portal Innovations, TMC Venture Fund, CE-Ventures, Linden Lake Ventures.
CrossBridge Bio is headquartered in Houston, United States.
CrossBridge Bio operates as a biotechnology company.
CrossBridge Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CrossBridge Bio — Funding & Investors." VCBacked, November 4, 2024, https://www.vcbacked.co/company/crossbridge-bio. Accessed August 1, 2026.
VCBacked. (2024). CrossBridge Bio — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/crossbridge-bio
{{cite web |title=CrossBridge Bio — Funding & Investors |url=https://www.vcbacked.co/company/crossbridge-bio |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated